Press Releases

NEW YORK , June 11, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. ( SIGA ) (Nasdaq: SIGA ), a commercial-stage pharmaceutical company focused on the health security market, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M.

NEW YORK , June 03, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. ( SIGA ) (NASDAQ: SIGA ), a commercial-stage pharmaceutical company focused on the health security market, today announced that it has entered into an international promotion agreement with Meridian Medical Technologies, Inc.

Raw Materials expected to be used to Support Manufacture of 363,070 Courses of Oral TPOXX NEW YORK , May 20, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. ( SIGA ) (NASDAQ: SIGA ), a commercial-stage pharmaceutical company focused on the health security market, today announced the exercise of an

NEW YORK , Feb. 21, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. ( SIGA ) (NASDAQ: SIGA ), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr. Phillip L. Gomez , SIGA’s Chief Executive Officer, will present at the 8 th Annual SVB Leerink

NEW YORK , Nov. 01, 2018 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. ( SIGA ) (NASDAQ: SIGA ), a commercial-stage pharmaceutical company focused on the health security market, today announced that it has entered into an agreement to sell its medical countermeasures priority review voucher (PRV) for

NEW YORK , Oct. 04, 2018 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. ( SIGA ) (NASDAQ: SIGA ), a commercial-stage pharmaceutical company focused on the health security market, today announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the United States

- Company Hosting Business Update Webcast Today at 4:30pm ET - NEW YORK , Sept. 27, 2018 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. ( SIGA ) (NASDAQ: SIGA ), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr. Phillip L.

NEW YORK , Sept. 17, 2018 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. ( SIGA ) (NASDAQ: SIGA ), a commercial-stage pharmaceutical company focused on the health security market, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M.

NEW YORK , Sept. 13, 2018 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. ( SIGA ) (NASDAQ: SIGA ), a commercial-stage pharmaceutical company focused on the health security market, today announced that that management will be ringing the Nasdaq Stock Market Opening Bell on Friday, September 14, 2018 .

- Contract Valued at Up to $629 Million – - Contract Includes Delivery of Oral and Intravenous (IV) Formulations of TPOXX; Development of IV TPOXX; Post-marketing Activities – NEW YORK , Sept. 10, 2018 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. ( SIGA ) (NASDAQ: SIGA ), a commercial-stage